Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

17 Jul 2014 07:00

RNS Number : 5362M
Xaar PLC
17 July 2014
 



17 July 2014

 

Xaar plc

 

Trading Statement

Xaar plc ("Xaar", "the Group" or "the Company"), the digital inkjet printing technology Group headquartered in Cambridge, UK, announces an update on trading.

 

Trading remains in line with the Board's expectations. Xaar expects to report revenue for the first half of 2014 of £60 million (H1 2013 - £67.2 million). As reported previously given normal seasonal patterns the Board expects a higher level of sales in the second half of the year, with full year revenue of approximately £130 million projected for 2014.

The Group continues to maintain a strong balance sheet with net cash at 30 June 2014 of £48.1 million (31 December 2013 - £53.5 million). As expected, cash balances reduced during the first half of the year due to investment in manufacturing and development assets, increased working capital and dividend payments.

The Company expects to announce Interim Results for 2014 on 28 August 2014.

 

 

Contacts

 

Xaar plc

Ian Dinwoodie, Chief Executive Officer

01223-423663

Alex Bevis, Finance Director

www.xaar.com

Tulchan Communications

Tom Buchanan

020-7353-4200

Christian Cowley

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEQLFFZDFXBBK
Date   Source Headline
23rd Dec 20117:02 amRNSTotal Voting Rights
23rd Dec 20117:01 amRNSBlocklisting Interim Review
23rd Dec 20117:00 amRNSIssue of Options
24th Nov 20119:58 amRNSHolding(s) in Company
18th Nov 20113:23 pmRNSBlocklisting Interim Review
17th Nov 20115:31 pmRNSHolding(s) in Company
21st Oct 201112:06 pmRNSHolding(s) in Company
20th Oct 20117:00 amRNSInterim Management Statement
11th Oct 201112:24 pmRNSHolding(s) in Company
4th Oct 201112:59 pmRNSTotal Voting Rights
30th Sep 20119:04 amRNSDirector/PDMR Shareholding
26th Sep 20115:50 pmRNSHolding(s) in Company
26th Aug 20115:21 pmRNSHolding(s) in Company
23rd Aug 20114:14 pmRNSDirector/PDMR Shareholding
18th Aug 20111:55 pmRNSHalf Yearly Report - Replacement
18th Aug 20117:00 amRNSInterim Management Statement
5th Aug 20112:59 pmRNSAdditional Listing
7th Jul 20117:00 amRNSInterim Trading Update
21st Jun 20114:34 pmRNSHolding(s) in Company
15th Jun 20117:00 amRNSHolding(s) in Company
9th Jun 20112:48 pmRNSDirector/PDMR Shareholding
8th Jun 20117:00 amRNSBoard Changes
17th May 20114:46 pmRNSResult of AGM
5th May 20117:00 amRNSNotice of 2011 AGM and AFR 2010
27th Apr 201111:54 amRNSGrant of Options
21st Apr 20117:00 amRNSInterim Management Statement
7th Apr 20118:00 amRNSDirector/PDMR Shareholding
31st Mar 201110:20 amRNSDirector/PDMR Shareholding
22nd Mar 20117:00 amRNSFinal Results
9th Mar 20114:14 pmRNSHolding(s) in Company
3rd Mar 20118:58 amRNSHolding(s) in Company
20th Jan 20117:00 amRNSYear End Trading Update
21st Dec 201011:12 amRNSGrant of Options
14th Dec 20107:00 amRNSDirectorate Change
18th Nov 20101:58 pmRNSDirector/PDMR Shareholding
15th Nov 201010:51 amRNSHolding(s) in Company
8th Nov 20102:51 pmRNSHolding(s) in Company
8th Nov 20101:48 pmRNSResult of General Meeting
8th Nov 20107:00 amRNSResults of the Placing and Open Offer
21st Oct 20104:33 pmRNSPublication of Prospectus
21st Oct 20104:33 pmRNSPublication of Prospectus
21st Oct 20107:00 amRNSIMS and fundraising
21st Oct 20107:00 amRNSIMS and fundraising
20th Sep 201011:57 amRNSHoldings in Company: Released in Error
20th Sep 201011:26 amRNSHolding(s) in Company
6th Sep 201010:03 amRNSHolding(s) in Company
6th Sep 201010:00 amRNSHolding(s) in Company
2nd Sep 20104:04 pmRNSHolding(s) in Company
24th Aug 201012:44 pmRNSHolding(s) in Company
18th Aug 20107:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.